Login / Signup

Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method.

Yoon-Young ChoiJung Kuk LeeHyun Soo KimDong-Wook KimHee Man KimDae Ryong Kang
Published in: Yonsei medical journal (2021)
In patients with inflammatory bowel disease, the preventive effect of drug exposure on colorectal cancer varies depending on the application of the landmark method. Hence, the possibility of immortal time bias should be considered.
Keyphrases
  • patients with inflammatory bowel disease